E Fund Management Co.,LTD. logo

E Fund Management Co.,LTD.

Asia, Hong Kong Island, Hong Kong, Central

Description

E Fund Management Co., Ltd. ("E Fund") is a fund management company.

Investor Profile

E Fund Management Co.,LTD. has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (25%)
  • Series C (25%)
  • Series D (25%)
  • Private Equity (25%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Consumer Electronics
  • Electronics
  • Biopharma
  • Health Care
  • Medical Device
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does E Fund Management Co.,LTD. frequently co-invest with?

Sheng Capital
Asia, Jiangxi, China, Jiujiang
Co-Investments: 1
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Sealand Capital
Europe, Syddanmark, Denmark, Københoved
Co-Investments: 1
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Xinhu Zhongbao Co Ltd
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Caitong Fund Management Co.
Asia, Shanghai, China, Shanghai
Co-Investments: 1
SA
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Harvest Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2

What are some of recent deals done by E Fund Management Co.,LTD.?

Loctek Ergonomic Technology

Ningbo, Zhejiang, China

Loctek Ergonomic Technology manufactures ergonomic products.

Consumer ElectronicsElectronicsManufacturing
Post Ipo EquitySep 30, 2021
Amount Raised: $108,570,542
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
InventisBio

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical
Series DSep 27, 2020
Amount Raised: $147,000,000
MicroPort Medbot

Shanghai, Shanghai, China

MicroPort Medbot develops and provides intelligent surgical solutions and clinical needs.

Health CareManufacturingMedicalMedical DeviceRobotics
Private EquitySep 7, 2020
Amount Raised: $512,407,584